![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | SIGLEC11 | Human | 1,2-dichloroethane | decreases expression | ISO | Siglecg (Mus musculus) | 6480464 | ethylene dichloride results in decreased expression of SIGLECG mRNA | CTD | PMID:28189721 and PMID:28960355 | SIGLEC11 | Human | 1,2-dimethylhydrazine | increases expression | ISO | Siglecg (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in increased expression of SIGLECG mRNA | CTD | PMID:22206623 | SIGLEC11 | Human | 2-palmitoylglycerol | increases expression | EXP | | 6480464 | 2-palmitoylglycerol results in increased expression of SIGLEC11 mRNA | CTD | PMID:37199045 | SIGLEC11 | Human | 4,4'-sulfonyldiphenol | increases expression | ISO | Siglecg (Mus musculus) | 6480464 | bisphenol S results in increased expression of SIGLECG mRNA | CTD | PMID:30951980 | SIGLEC11 | Human | aflatoxin B1 | decreases methylation | EXP | | 6480464 | Aflatoxin B1 results in decreased methylation of SIGLEC11 intron | CTD | PMID:30157460 | SIGLEC11 | Human | aristolochic acid A | increases expression | EXP | | 6480464 | aristolochic acid I results in increased expression of SIGLEC11 mRNA | CTD | PMID:33212167 | SIGLEC11 | Human | benzo[a]pyrene | decreases expression | ISO | Siglecg (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased expression of SIGLECG mRNA | CTD | PMID:21569818 | SIGLEC11 | Human | benzo[a]pyrene | affects methylation | EXP | | 6480464 | Benzo(a)pyrene affects the methylation of SIGLEC11 exon | CTD | PMID:30157460 | SIGLEC11 | Human | benzo[a]pyrene | increases methylation | EXP | | 6480464 | Benzo(a)pyrene results in increased methylation of SIGLEC11 promoter | CTD | PMID:27901495 | SIGLEC11 | Human | bisphenol A | increases expression | ISO | Siglecg (Mus musculus) | 6480464 | bisphenol A results in increased expression of SIGLECG mRNA | CTD | PMID:26063408 and PMID:32156529 | SIGLEC11 | Human | bisphenol F | increases expression | ISO | Siglecg (Mus musculus) | 6480464 | bisphenol F results in increased expression of SIGLECG mRNA | CTD | PMID:30951980 | SIGLEC11 | Human | bisphenol F | decreases expression | ISO | Siglecg (Mus musculus) | 6480464 | bisphenol F results in decreased expression of SIGLECG mRNA | CTD | PMID:38685157 | SIGLEC11 | Human | buta-1,3-diene | decreases expression | ISO | Siglecg (Mus musculus) | 6480464 | 1 and 3-butadiene results in decreased expression of SIGLECG mRNA | CTD | PMID:29038090 | SIGLEC11 | Human | carbon nanotube | decreases expression | ISO | Siglecg (Mus musculus) | 6480464 | Nanotubes and Carbon analog results in decreased expression of SIGLECG mRNA | CTD | PMID:25554681 | SIGLEC11 | Human | dimethylarsinic acid | multiple interactions | ISO | Siglecg (Mus musculus) | 6480464 | [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SIGLECG mRNA | CTD | PMID:34876320 | SIGLEC11 | Human | dioxygen | multiple interactions | ISO | Siglecg (Mus musculus) | 6480464 | [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SIGLECG mRNA | CTD | PMID:30529165 | SIGLEC11 | Human | diquat | decreases expression | ISO | Siglecg (Mus musculus) | 6480464 | Diquat results in decreased expression of SIGLECG mRNA | CTD | PMID:36851058 | SIGLEC11 | Human | lipopolysaccharide | multiple interactions | EXP | | 6480464 | [S-(1 and 2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of SIGLEC11 mRNA | CTD | PMID:35811015 | SIGLEC11 | Human | methylarsonic acid | multiple interactions | ISO | Siglecg (Mus musculus) | 6480464 | [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SIGLECG mRNA | CTD | PMID:34876320 | SIGLEC11 | Human | nitrates | multiple interactions | ISO | Siglecg (Mus musculus) | 6480464 | [Particulate Matter results in increased abundance of Nitrates] which results in increased expression of SIGLECG mRNA | CTD | PMID:35964746 | SIGLEC11 | Human | ozone | multiple interactions | ISO | Siglecg (Mus musculus) | 6480464 | [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of SIGLECG mRNA | CTD | PMID:34911549 | SIGLEC11 | Human | perfluorohexanesulfonic acid | increases expression | ISO | Siglecg (Mus musculus) | 6480464 | perfluorohexanesulfonic acid results in increased expression of SIGLECG mRNA | CTD | PMID:37995155 | SIGLEC11 | Human | S-(1,2-dichlorovinyl)-L-cysteine | multiple interactions | EXP | | 6480464 | [S-(1 and 2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of SIGLEC11 mRNA | CTD | PMID:35811015 | SIGLEC11 | Human | silver atom | increases expression | ISO | Siglecg (Mus musculus) | 6480464 | Silver results in increased expression of SIGLECG mRNA | CTD | PMID:27131904 | SIGLEC11 | Human | silver(0) | increases expression | ISO | Siglecg (Mus musculus) | 6480464 | Silver results in increased expression of SIGLECG mRNA | CTD | PMID:27131904 | SIGLEC11 | Human | sodium arsenate | multiple interactions | ISO | Siglecg (Mus musculus) | 6480464 | [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SIGLECG mRNA | CTD | PMID:34876320 | SIGLEC11 | Human | sodium arsenite | increases expression | EXP | | 6480464 | sodium arsenite results in increased expression of SIGLEC11 mRNA | CTD | PMID:38568856 | SIGLEC11 | Human | sodium arsenite | increases expression | ISO | Siglecg (Mus musculus) | 6480464 | sodium arsenite results in increased expression of SIGLECG mRNA | CTD | PMID:36209798 | SIGLEC11 | Human | sodium arsenite | multiple interactions | ISO | Siglecg (Mus musculus) | 6480464 | [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SIGLECG mRNA | CTD | PMID:34876320 | SIGLEC11 | Human | tetraphene | increases expression | ISO | Siglecg (Mus musculus) | 6480464 | benz(a)anthracene results in increased expression of SIGLECG mRNA | CTD | PMID:26377693 | SIGLEC11 | Human | valproic acid | increases methylation | EXP | | 6480464 | Valproic Acid results in increased methylation of SIGLEC11 gene | CTD | PMID:29154799 | |